| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/01/2010 | WO2010074223A1 Coating material for solid medicine and solid medicine formed with same |
| 07/01/2010 | WO2010074183A1 Transdermal preparation |
| 07/01/2010 | WO2010074182A1 Transdermal preparation |
| 07/01/2010 | WO2010074178A1 Adhesive preparation for external use |
| 07/01/2010 | WO2010074172A1 Method for producing liposome and method for dissolving cholesterol |
| 07/01/2010 | WO2010074163A1 Complex and manufacturing method therefor |
| 07/01/2010 | WO2010074113A1 Dry powder pharmaceutical composition for inhalation |
| 07/01/2010 | WO2010073993A1 Pressure-sensitive adhesive tape package |
| 07/01/2010 | WO2010073388A1 Laser ablation-in-liquid system and method of subdividing solid material |
| 07/01/2010 | WO2010073327A1 Patch |
| 07/01/2010 | WO2010073326A1 Percutaneous absorption preparation |
| 07/01/2010 | WO2010072950A1 Formulation for delivering lipid-lowering drugs by oral transmucosal administration |
| 07/01/2010 | WO2010072844A1 Implantable devices for treating hiv |
| 07/01/2010 | WO2010072745A1 Method to authenticate genuine tablets manufactured by compressing powder |
| 07/01/2010 | WO2010072640A1 Method for stabilizing polymers |
| 07/01/2010 | WO2010072621A2 Process for the preparation of a peptide powder form |
| 07/01/2010 | WO2010072422A1 Use of a foamable composition essentially free of pharmaceutically active ingredients for the treatment of human skin |
| 07/01/2010 | WO2010072421A2 Hydrogel composition for the treatment of dermatological disorders |
| 07/01/2010 | WO2010072420A2 Compositions comprising hemp oil for treating topical diseases, especially hand-foot syndrome |
| 07/01/2010 | WO2010072419A2 Enema preparations and their use |
| 07/01/2010 | WO2010072401A1 Low dose controlled release tablet |
| 07/01/2010 | WO2010072109A1 A sustained release system for tumor treating medicament |
| 07/01/2010 | WO2010072105A1 A enteric formulation of duloxetine and its core and prepration method |
| 07/01/2010 | WO2010072018A1 Crosslink dextran magnetic complex microparticles and the preparation method and using method thereof |
| 07/01/2010 | WO2010052665A3 Gold nanoparticles coated with polyelectrolytes and albumin |
| 07/01/2010 | WO2010046933A3 Pharmaceutical compositions of taste-masked linezolid |
| 07/01/2010 | WO2010043408A3 Microencapsulated fesoterodine |
| 07/01/2010 | WO2010041279A3 Sustained release drug delivery system |
| 07/01/2010 | WO2010039496A3 Nanocarriers for drug delivery |
| 07/01/2010 | WO2010033832A3 Estriol formulations |
| 07/01/2010 | WO2010033726A3 Drug delivery composition comprising a self-assembled gelator |
| 07/01/2010 | WO2010029571A3 Modified release ramipril compositions and uses thereof |
| 07/01/2010 | WO2010027404A3 Stable formulation comprising therapeutic polypeptides for oral administration |
| 07/01/2010 | WO2010016686A3 Nanoemulsion for local administration |
| 07/01/2010 | WO2010008719A9 Oral pharmaceutical formulations of vla-4 antagonists |
| 07/01/2010 | WO2009150238A3 Gastro-resistant pharmaceutical oral compositions comprising duloxetine or its pharmaceutically acceptable derivatives |
| 07/01/2010 | WO2009120619A3 Nuclease compositions, methods of making and using such compositions, and systems for pulmonary delivery of such compositions |
| 07/01/2010 | US20100168807 Bioactive terpolymer compositions and methods of making and using same |
| 07/01/2010 | US20100168746 Reduced pressure augmentation of microfracture procedures for cartilage repair |
| 07/01/2010 | US20100168563 device and method for the prolonged delivery of an active agent to a body cavity |
| 07/01/2010 | US20100168401 Method, composition and kit for detecting phosphatidylserine (PS) on cell membranes |
| 07/01/2010 | US20100168381 Conjugates of membrane translocating agents and pharmaceutically active agents |
| 07/01/2010 | US20100168187 Therapeutic combination |
| 07/01/2010 | US20100168148 Pharmaceutical formulation containing gelling agent |
| 07/01/2010 | US20100168073 Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
| 07/01/2010 | US20100168059 Hyaluronic acid nutritional supplements and methods of using the same |
| 07/01/2010 | US20100167985 Oral insulin composition and methods of making and using thereof |
| 07/01/2010 | US20100166876 Loading of hydrophobic drugs into hydrophilic polymer delivery systems |
| 07/01/2010 | US20100166875 Colouring composition comprising starch derivatives as a hydrocolloid |
| 07/01/2010 | US20100166874 Technology for Preparation of Macromolecular Microspheres |
| 07/01/2010 | US20100166873 Eutectic-Based Self-Nanoemulsified Drug Delivery System |
| 07/01/2010 | US20100166872 Novel improved compositions for cancer therapy |
| 07/01/2010 | US20100166870 Method for Coating Nanoparticles |
| 07/01/2010 | US20100166869 Methods and compositions for treating pulmonary hypertension |
| 07/01/2010 | US20100166868 Filmy Compositions |
| 07/01/2010 | US20100166867 Novel administration form of osteogenic protein complexes |
| 07/01/2010 | US20100166866 Matrix compositions for controlled delivery of drug substances |
| 07/01/2010 | US20100166865 Nanoparticle compositions |
| 07/01/2010 | US20100166864 Matrix-based pulse release pharmaceutical formulation |
| 07/01/2010 | US20100166863 Biodegradable copolymer hydrogels |
| 07/01/2010 | US20100166862 Local Complement Inhibition for Treatment of Complement-Mediated Disorders |
| 07/01/2010 | US20100166861 Pharmaceutical formulations of sevalamer, or salts thereof, and copovidone |
| 07/01/2010 | US20100166860 Medicine for treating gastrointestinal disorder including acquired lactose-intolerance irritable bowel syndrome |
| 07/01/2010 | US20100166859 Novel nutraceutical compositions and use thereof |
| 07/01/2010 | US20100166858 Modified release formulations containing drug-ion exchange resin complexes |
| 07/01/2010 | US20100166857 Pharmaceutical dosage forms and methods of manufacturing same |
| 07/01/2010 | US20100166856 Pharmaceutical composition in the form of coated microspheres for the modified release of a muscle relaxant and an nsaid |
| 07/01/2010 | US20100166855 Oral insulin composition and methods of making and using thereof |
| 07/01/2010 | US20100166854 Electrospun matrices for delivery of hydrophilic and lipophilic compounds |
| 07/01/2010 | US20100166853 Coated preparation |
| 07/01/2010 | US20100166852 Cream gels comprising at least one retinoid and benzoyl peroxide |
| 07/01/2010 | US20100166851 Composition having lipolytic activity, production method thereof and use of the composition |
| 07/01/2010 | US20100166850 Eprosartan mesylate crystalline particles and a process for preparing pure eprosartan |
| 07/01/2010 | US20100166849 Glutathione based delivery system |
| 07/01/2010 | US20100166848 Liposomal formulations for treating cancer |
| 07/01/2010 | US20100166847 Method for coating fine particles with lipid membrane |
| 07/01/2010 | US20100166846 Management of myoclonus with oral liposomal reduced glutathione |
| 07/01/2010 | US20100166845 Individualized cancer therapy |
| 07/01/2010 | US20100166844 Polymer particle dispersion, composition containing the same and cosmetic treatment method |
| 07/01/2010 | US20100166843 Pharmaceutical composition comprising a campothecin derivative |
| 07/01/2010 | US20100166842 Amphiphilic substances and functionalized lipid vesicles including the same |
| 07/01/2010 | US20100166840 Liposome having lipid membrane containing bacterial cell component |
| 07/01/2010 | US20100166839 Non peptidic renin inhibitors nitroderivatives |
| 07/01/2010 | US20100166838 Methods And Compositions For Modulating Keratinocyte Function |
| 07/01/2010 | US20100166837 1,(3,)5-substituted imidazoles, their use in the treatment of hypertension and methods for their preparation |
| 07/01/2010 | US20100166836 Transdermal Therapeutic System for Volatile and/or Thermo-Labile Substances |
| 07/01/2010 | US20100166834 Preparations based on fibrinogen and sulfated polysaccharides |
| 07/01/2010 | US20100166833 Compositions, articles and methods for preventing or reducing tobacco-associated damage |
| 07/01/2010 | US20100166832 Silver coated nylon fibers and associated methods of manufacture and use |
| 07/01/2010 | US20100166831 Microencapsulated Nucleotide Formulations for Aquaculture and Land Animal Feeds |
| 07/01/2010 | US20100166829 Active agent eluting matrices with particulates |
| 07/01/2010 | US20100166828 Artificial bone capable of being absorbed and replaced by autogenous bone and its production method |
| 07/01/2010 | US20100166827 Periostin induces proliferation of cardiomyocytes and promotes cardiac regeneration |
| 07/01/2010 | US20100166825 Treating and/or preventing urinary incontinence using prodrugs of gaba analogs |
| 07/01/2010 | US20100166823 Biopolymeric membrane for wound protection and repair |
| 07/01/2010 | US20100166821 Anti-Inflammatory, Radioprotective, and Longevity Enhancing Capabilities of Cerium Oxide Nanoparticles |
| 07/01/2010 | US20100166820 Copolymers having polyisobutylene and biodegradable polymer segments |
| 07/01/2010 | US20100166819 Transforming Growth Factor Modulators |
| 07/01/2010 | US20100166811 Gras composition for intranasal delivery of parathyroid hormone |
| 07/01/2010 | US20100166810 Combination tablet with chewable outer layer |